Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

刘宝东 ,  支修益

首都医科大学宣武医院胸外科（北京 100053）;

Corresponding author：

支修益, Email: xiuyizhi@aliyun.com

Keywords：

影像引导; 射频消融; 肺部肿瘤; 专家共识

DOI：

10.7507/1007-4848.20150159

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

肺癌是最常见的恶性肿瘤之一，我国每年大约有60万人死于肺癌，因此愈发引起关注。由中华医学会胸心血管外科学会肺癌学组组织，首都医科大学宣武医院胸外科刘宝东起草，支修益组织国内相关专家在2014年10月至2014年11月通过讨论、电子邮件等形式，反复征求参审专家的意见，达成了影像引导射频消融治疗肺部肿瘤的专家共识现已公布，旨在规范操作技术、进行疗效评估、减少并发症和提高治疗效果。

Citation： 刘宝东, 支修益. Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(7): 621-628. doi: 10.7507/1007-4848.20150159 Copy

1.	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5):E359-E386.
2.	陈万青, 张思维, 邹小农, 等. 2004-2005年中国肺癌死亡情况分析. 中华预防医学杂志, 2010, 44(5):378-382.
3.	She J, Yang P, Hong Q, et al. Lung cancer in China:challenge and inteventions. Chest, 2013, 143(4):1117-1126.
4.	Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol, 2009, 20(7suppl):474-485.
5.	Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung AJR Am J Roentgenol, 2000, 174(1):57-59.
6.	Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer:results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg, 2007, 134(5):1306-1312.
7.	Hiraki T, GobaraH, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2011, 142(1):24-30.
8.	Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation:long-term safety and efficacy in 153 patients. Radiology, 2007, 243(1):268-275.
9.	Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2008, 137(1):160-166.
10.	Pennathur A, Abbas G, Gooding WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann ThoracSurg, 2009, 88(5):1601-1608.
11.	Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours:a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol, 2008, 9(7):621-628.
12.	Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer:a prospective intention-to-treat study. J Thorac Oncol, 2011, 6(12):2044-2051.
13.	刘宝东, 刘磊, 李岩, 等. 射频消融治疗100例肺部肿瘤的远期疗效. 中国肺癌杂志, 2011, 14(4):335-339.
14.	Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy:a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol, 2000, 174(2):323-331.
15.	Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac cardiovasc surg, 2011, 142(1):24-30.
16.	Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer:review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology, 2010, 254(1):301-307.
17.	Lanuti M, Sharma A, Willers H, et al. Radiofrequency ablation for stage I non-small cell lung cancer:management of locoregional recurrence. Ann Thorac Surg, 2012, 93(3):921-927.
18.	Li XQ, Zhang Y, Huang DB, et al. Value of C-arm computed tomography in radiofrequency ablation of small lung lesions. Genet Mol Res, 2014, 13(3):6027-6036.
19.	Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation:standardization of terminology and reporting criteria. Radiology, 2005, 235(3):728-739.
20.	Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6):1765-1774.
21.	Kashima M, Yamakado K, Takaki H, et al. Complications after 1,000 lung radiofrequency ablation sessions in 420 patients:a single center's experiences. AJR Am J Roentgenol, 2011, 197(40):W576-W580.
22.	Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomographyguided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol, 2008, 31(1):122-130.
23.	Hiraki T, Gobara H, Shibamoto K. et al. Technique for creationof artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors:report of seven cases. J Vasc Interv Radiol, 2011, 22(4):503-506.
24.	Lee EW, Suh RD, Zeidler MR, et al. Ablation of subpleural lung malignancy:reduced pain using an artificially created pneumothorax. Cardiovasc Intervent Radiol, 2009, 32(4):833-836.
25.	Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors:incidence and risk factors. Radiology, 2006, 241(1):275-283.
26.	Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies:a large single-center experience. Cancer, 2007, 109(7):1397-1405.
27.	Abtin FG, Eradat J, Gutierrez AJ, et al. Radiofrequency ablation of lung tumors:imaging features of the postablationzone. Radiographics, 2012, 32(4):947-969.
28.	Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation:computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5):989-997.
29.	Gadaleta CD, Solbiati L, Mattioli V, et al. Unresectable lung malignancy:combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology, 2013, 267(2):627-637.
30.	Shen Y, Zhong M, Jiang W, et al. Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer. BMC Surg, 2013, 13(1):19.
31.	Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest, 2006, 129(3):738-745.
32.	Li X, Zhao M, Wang J. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR Am J Roentgenol, 2013, 201(6):1362-1367.
33.	Weickhardt AJ, Scheier B, Burke JM, et al. Local ablative therapy of oligo progressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer. J Thorac Oncol, 2012, 7(2):1807-1814.
34.	Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol, 2012, 81(2):395-399.
35.	Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg, 2010, 211(1):68-72.
36.	Renaud S, Falcoz PE, Olland A, et al. Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?. Interact Cardiovasc Thorac Surg, 2013, 16(1):68-73.
37.	Bilal H, Mahmood S, Rajashanker B, et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?. Interact Cardiovasc Thorac Surg, 2012, 15(2):258-265.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5):E359-E386.
2. 陈万青, 张思维, 邹小农, 等. 2004-2005年中国肺癌死亡情况分析. 中华预防医学杂志, 2010, 44(5):378-382.
3. She J, Yang P, Hong Q, et al. Lung cancer in China:challenge and inteventions. Chest, 2013, 143(4):1117-1126.
4. Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol, 2009, 20(7suppl):474-485.
5. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung AJR Am J Roentgenol, 2000, 174(1):57-59.
6. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer:results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg, 2007, 134(5):1306-1312.
7. Hiraki T, GobaraH, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2011, 142(1):24-30.
8. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation:long-term safety and efficacy in 153 patients. Radiology, 2007, 243(1):268-275.
9. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2008, 137(1):160-166.
10. Pennathur A, Abbas G, Gooding WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann ThoracSurg, 2009, 88(5):1601-1608.
11. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours:a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol, 2008, 9(7):621-628.
12. Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer:a prospective intention-to-treat study. J Thorac Oncol, 2011, 6(12):2044-2051.
13. 刘宝东, 刘磊, 李岩, 等. 射频消融治疗100例肺部肿瘤的远期疗效. 中国肺癌杂志, 2011, 14(4):335-339.
14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy:a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol, 2000, 174(2):323-331.
15. Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac cardiovasc surg, 2011, 142(1):24-30.
16. Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer:review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology, 2010, 254(1):301-307.
17. Lanuti M, Sharma A, Willers H, et al. Radiofrequency ablation for stage I non-small cell lung cancer:management of locoregional recurrence. Ann Thorac Surg, 2012, 93(3):921-927.
18. Li XQ, Zhang Y, Huang DB, et al. Value of C-arm computed tomography in radiofrequency ablation of small lung lesions. Genet Mol Res, 2014, 13(3):6027-6036.
19. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation:standardization of terminology and reporting criteria. Radiology, 2005, 235(3):728-739.
20. Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6):1765-1774.
21. Kashima M, Yamakado K, Takaki H, et al. Complications after 1,000 lung radiofrequency ablation sessions in 420 patients:a single center's experiences. AJR Am J Roentgenol, 2011, 197(40):W576-W580.
22. Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomographyguided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol, 2008, 31(1):122-130.
23. Hiraki T, Gobara H, Shibamoto K. et al. Technique for creationof artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors:report of seven cases. J Vasc Interv Radiol, 2011, 22(4):503-506.
24. Lee EW, Suh RD, Zeidler MR, et al. Ablation of subpleural lung malignancy:reduced pain using an artificially created pneumothorax. Cardiovasc Intervent Radiol, 2009, 32(4):833-836.
25. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors:incidence and risk factors. Radiology, 2006, 241(1):275-283.
26. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies:a large single-center experience. Cancer, 2007, 109(7):1397-1405.
27. Abtin FG, Eradat J, Gutierrez AJ, et al. Radiofrequency ablation of lung tumors:imaging features of the postablationzone. Radiographics, 2012, 32(4):947-969.
28. Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation:computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5):989-997.
29. Gadaleta CD, Solbiati L, Mattioli V, et al. Unresectable lung malignancy:combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology, 2013, 267(2):627-637.
30. Shen Y, Zhong M, Jiang W, et al. Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer. BMC Surg, 2013, 13(1):19.
31. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest, 2006, 129(3):738-745.
32. Li X, Zhao M, Wang J. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR Am J Roentgenol, 2013, 201(6):1362-1367.
33. Weickhardt AJ, Scheier B, Burke JM, et al. Local ablative therapy of oligo progressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer. J Thorac Oncol, 2012, 7(2):1807-1814.
34. Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol, 2012, 81(2):395-399.
35. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg, 2010, 211(1):68-72.
36. Renaud S, Falcoz PE, Olland A, et al. Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?. Interact Cardiovasc Thorac Surg, 2013, 16(1):68-73.
37. Bilal H, Mahmood S, Rajashanker B, et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?. Interact Cardiovasc Thorac Surg, 2012, 15(2):258-265.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Expert Consensus for Image-Guided Radiofrequency Ablation of Pulmonary Tumors

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content